Goal 2: Reduce Human Disease

Regeneration of Failing Heart while Resting on Left Ventricular Assist Device

Heart transplant is the ultimate treatment for AHA stage-D heart failure. Due to availability, heart transplants will be limited to about 2,500 per year. Patients with AHA stage-D heart failure has estimated prevalence of 0.2% for age >45. Thus, patients in need far exceed organs available. A failed heart has very challenging environment for cellular therapy. Left ventricular assist device (LVAD) can offload the heart to mechanically provide a better environment. Thus, application of transcription factors and/or cellular strategies maybe able to regenerate failing hearts while resting on LVADs.

Tags (Keywords associated with the idea)


-4 net votes
3 up votes
7 down votes
Idea No. 760